Duque-Afonso, J., Lin, C., Han, K., Morgens, D. W., Jeng, E. E., Weng, Z., . . . Cleary, M. L. (2018). CBP modulates sensitivity to dasatinib in pre-BCR+ acute lymphoblastic leukemia. Cancer Res.
Citación estilo ChicagoDuque-Afonso, Jesús, et al. "CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia." Cancer Res 2018.
Cita MLADuque-Afonso, Jesús, et al. "CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia." Cancer Res 2018.
Precaución: Estas citas no son 100% exactas.